Brief report · 30 Jun 2026
Conference abstractPublished 31 Aug 2018
Formulation and solid-state characterisation of a novel benzanilide co-crystal of the anti-HIV drug Efavirenz
Mangosuthu University of Technology, South Africa
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
HIV/AIDS has had a crippling socio-economic effect on developing countries in Africa. EFV (Efavirenz) is generally used to treat this pathology. However, its clinical efficacy is reduced by its limited water solubility. Our recent efforts were to discover new multicomponent molecular crystals of EFV to further enhance the solubility of EFV, which has led to the formulation of a novel BZA (benzanilide) CC (co-crystal). The molecular complex was characterized by X-ray Powder Diffraction (XRD) and FTIR (Fourier transform infrared) spectroscopy. FTIR data showed a shift in the N-H stretch of the amide group of EFV from 3,312.39 cm-1 to 3,299.71 cm-1 and the C = O frequency from 1,749.70 cm-1 to 1,739.87 cm-1 suggesting that the N-H and C = O functionalities of EFV are participating in hydrogen bonding with the N-H and C = O moieties of BZA in the EFV-BZA complex, indicative of improved water solubility. Both the XRD patterns of BZA and EFV show characteristic peaks, however, in the XRD pattern of EFVBZA CC, one unique peak appeared which is absent in both EFV and BZA at 30.8005° (100% intensity) suggesting the formation of a new solid phase. The results from this study are significant in understanding the complexity of these scarce EFV based CCs and can be used to advance the development of new solid-state structures with improved physicochemical properties.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Maryam A. Jordaan”
- BylineArticles whose byline prints “Michael M. Shapi”
